Trial Profile
Transplacentar pharmacokinetics of remifentanil
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 11 Feb 2022 Status changed from completed to discontinued.
- 01 May 2021 Status changed from recruiting to completed.
- 07 Oct 2011 New trial record